<?xml version="1.0" encoding="UTF-8"?>
<p>RWHAP grant recipients, rather than the HRSA HIV/AIDS Bureau (HAB), identifies the service categories that they will deliver to PLWH based on local epidemiologic trends, consumer engagement, and workforce and infrastructure availability. In rural areas of the United States, injection drug use is a major driver of HIV transmission, and rural counties have been identified as most vulnerable to the rapid spread of HIV and hepatitis C (HCV) [
 <xref rid="pone.0230121.ref008" ref-type="bibr">8</xref>, 
 <xref rid="pone.0230121.ref021" ref-type="bibr">21</xref>, 
 <xref rid="pone.0230121.ref022" ref-type="bibr">22</xref>]. Recent outbreaks of HIV and HCV driven by injection opioid use in rural areas suggest that the current U.S. opioid epidemic has the potential to drastically impact the HIV and healthcare environment in many rural communities [
 <xref rid="pone.0230121.ref023" ref-type="bibr">23</xref>â€“
 <xref rid="pone.0230121.ref027" ref-type="bibr">27</xref>]. Therefore, the presence of RWHAP service providers in rural areas at high risk for HIV and HCV outbreaks is crucial to meeting the needs and improving health outcomes for PLWH in rural areas.
</p>
